Jul. 12, 2024
Nichino Mexico S. de R.L. de C.V. announces the addition of Apta® (Tolfenpyrad) insecticide to its portfolio. This innovative solution, with an active ingredient patented by its parent company, Nihon Nohyaku Co., Ltd., will provide the customers with a wide variety of solutions and the specialized technical support that characterizes the company. As a subsidiary of Nichino America Inc. and Nihon Nohyaku, Nichino Mexico is pleased to commercialize this product in the Mexican market, allowing it to expand its presence in crops such as solanaceae, berries, avocado, among others, and provide support to farmers in the control of pests of economic importance.
As of July 11, 2024, Nichino Mexico will commercialize Apta through its distributor network. This addition marks an important milestone for Nichino Mexico as it expands its portfolio and presence in a variety of crops. By initiating the commercialization of Apta, the company looks forward to providing the customers with greater benefits:
Expertise and innovation: Apta has been and will continue to be developed by the company, as well as Nichino companies globally, which contributes to a deeper understanding of the compound and its performance in the field.
Technical support: As the main marketer, Nichino Mexico will provide comprehensive technical support, training and resources to optimize the use and results of the product.
Commitment to quality: Direct marketing allows the company to maintain strict quality control standards, ensuring that the customers receive the best possible products for their agricultural needs.
"We are delighted to expand our portfolio with products like Apta that allow us to participate in high-value crops, expand our presence in the field and support our growers as well as support our business partners by complementing our value offering," said Justo Acosta, general manager of Nichino Mexico.
To know more formulation and adjuvant technologies, please click the following picture to read / download AgroPages' magazine <<2024 Formulation&Adjuvant Technology>>.
Subscribe Email: | * | |
Name: | ||
Mobile Number: | ||
0/1200